Circadian Disruption and Breast Cancer: an Epigenetic Link?

Overview

Journal Oncotarget

Specialty Oncology

Date 2015 Jul 30

PMID 26220712

Citations 14

Authors

David Z Kochan

Olga Kovalchuk

Affiliations

Soon will be listed here.

Abstract

Breast cancer is already the most common malignancy affecting women worldwide, and evidence is mounting that breast cancer induced by circadian disruption (CD) is a warranted concern. Numerous studies have investigated various aspects of the circadian clock in relation to breast cancer, and evidence from these studies indicates that melatonin and the core clock genes can play a crucial role in breast cancer development. Even though epigenetics has been increasingly recognized as a key player in the etiology of breast cancer and linked to circadian rhythms, and there is evidence of overlap between epigenetic deregulation and breast cancer induced by circadian disruption, only a handful of studies have directly investigated the role of epigenetics in CD-induced breast cancer. This review explores the circadian clock and breast cancer, and the growing role of epigenetics in breast cancer development and circadian rhythms. We also summarize the current knowledge and next steps for the investigation of the epigenetic link in CD-induced breast cancer.

Citing Articles

Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.

Li D, Zhou T, Gao J, Wu G, Yang G J Cancer Res Clin Oncol. 2024; 150(9):419.

PMID: 39266868 PMC: 11393214. DOI: 10.1007/s00432-024-05917-w.

Differential Regulation of Circadian Clock Genes by UV-B Radiation and 1,25-Dihydroxyvitamin D: A Pilot Study during Different Stages of Skin Photocarcinogenesis.

Lamnis L, Christofi C, Stark A, Palm H, Roemer K, Vogt T Nutrients. 2024; 16(2).

PMID: 38257148 PMC: 10820546. DOI: 10.3390/nu16020254.

Circadian clock gene expression and polymorphism in non-segmental vitiligo.

Farag A, Badr E, Ibrahim A Mol Biol Rep. 2024; 51(1):142.

PMID: 38236441 PMC: 10796645. DOI: 10.1007/s11033-023-09109-6.

Latest advances in the study of non-coding RNA-mediated circadian rhythm disorders causing endometrial cancer.

Zheng L, Chen S, Zhou L, Huang Q, Chen J, Chen W Front Oncol. 2023; 13:1277543.

PMID: 38074657 PMC: 10703048. DOI: 10.3389/fonc.2023.1277543.

Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer.

Pramanik S, Halder A, Mukherjee U, Kumar D, Dey Y, R M Front Chem. 2022; 10:948217.

PMID: 36034650 PMC: 9411967. DOI: 10.3389/fchem.2022.948217.

References

Blask D, Dauchy R, Sauer L, Krause J, Brainard G . Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat. 2003; 79(3):313-20. DOI: 10.1023/a:1024030518065. View

Arendt J . Melatonin and human rhythms. Chronobiol Int. 2006; 23(1-2):21-37. DOI: 10.1080/07420520500464361. View

Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

Liu C, Calin G, Volinia S, Croce C . MicroRNA expression profiling using microarrays. Nat Protoc. 2008; 3(4):563-78. DOI: 10.1038/nprot.2008.14. View

Na Y, Sung J, Lee S, Lee Y, Choi Y, Park W . Comprehensive analysis of microRNA-mRNA co-expression in circadian rhythm. Exp Mol Med. 2009; 41(9):638-47. PMC: 2753657. DOI: 10.3858/emm.2009.41.9.070. View

Xiao L, Chang A, Zang M, Bi H, Li S, Wang M . Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells. PLoS One. 2014; 9(5):e95878. PMC: 4008427. DOI: 10.1371/journal.pone.0095878. View

Hoffman A, Yi C, Zheng T, Stevens R, Leaderer D, Zhang Y . CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 2010; 70(4):1459-68. PMC: 3188957. DOI: 10.1158/0008-5472.CAN-09-3798. View

Lee Y, Kim M, Han J, Yeom K, Lee S, Baek S . MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20):4051-60. PMC: 524334. DOI: 10.1038/sj.emboj.7600385. View

Coticchia C, Revankar C, Deb T, Dickson R, Johnson M . Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat. 2008; 115(3):545-60. PMC: 3736740. DOI: 10.1007/s10549-008-0097-z. View

10.

Weigel R, deConinck E . Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res. 1993; 53(15):3472-4. View

11.

Liu K, Wang R . MicroRNA-mediated regulation in the mammalian circadian rhythm. J Theor Biol. 2012; 304:103-10. DOI: 10.1016/j.jtbi.2012.03.037. View

12.

Knutsson A, Alfredsson L, Karlsson B, Akerstedt T, Fransson E, Westerholm P . Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Scand J Work Environ Health. 2012; 39(2):170-177. DOI: 10.5271/sjweh.3323. View

13.

Park S, Seo A, Jung H, Gwak J, Jung N, Cho N . Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer. PLoS One. 2014; 9(6):e100429. PMC: 4074093. DOI: 10.1371/journal.pone.0100429. View

14.

Folkard S . Do permanent night workers show circadian adjustment? A review based on the endogenous melatonin rhythm. Chronobiol Int. 2008; 25(2):215-24. DOI: 10.1080/07420520802106835. View

15.

Reppert S, Weaver D . Coordination of circadian timing in mammals. Nature. 2002; 418(6901):935-41. DOI: 10.1038/nature00965. View

16.

Frankel L, Christoffersen N, Jacobsen A, Lindow M, Krogh A, Lund A . Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2007; 283(2):1026-33. DOI: 10.1074/jbc.M707224200. View

17.

Abrahamson E, Moore R . Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res. 2001; 916(1-2):172-91. DOI: 10.1016/s0006-8993(01)02890-6. View

18.

Fujita S, Iba H . Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates. Bioinformatics. 2007; 24(3):303-8. DOI: 10.1093/bioinformatics/btm589. View

19.

Hon G, Hawkins R, Caballero O, Lo C, Lister R, Pelizzola M . Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 2011; 22(2):246-58. PMC: 3266032. DOI: 10.1101/gr.125872.111. View

20.

Chen C, Li L, Lodish H, Bartel D . MicroRNAs modulate hematopoietic lineage differentiation. Science. 2003; 303(5654):83-6. DOI: 10.1126/science.1091903. View